BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21296616)

  • 21. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
    Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
    Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial progenitor cells and cardiovascular cell-based therapies.
    Mund JA; Ingram DA; Yoder MC; Case J
    Cytotherapy; 2009; 11(2):103-13. PubMed ID: 19241233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of notch signaling in endothelial progenitor cell biology.
    Kwon SM; Alev C; Asahara T
    Trends Cardiovasc Med; 2009 Jul; 19(5):170-3. PubMed ID: 20005477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of marrow-derived endothelial cells in vascularization.
    Larrivée B; Karsan A
    Handb Exp Pharmacol; 2007; (180):89-114. PubMed ID: 17554506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems.
    Oztürk MA; Güven GS; Haznedaroglu IC
    Med Hypotheses; 2004; 63(5):866-74. PubMed ID: 15488662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Renaissance of the renin-angiotensin system in the pathogenesis and therapy of arterial hypertension].
    Horký K
    Cas Lek Cesk; 1989 Sep; 128(37):1161-5. PubMed ID: 2805032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renin-angiotensin system and the developing retinal vasculature.
    Sarlos S; Wilkinson-Berka JL
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ONTARGET still OFF-TARGET?
    Lambers Heerspink HJ; de Zeeuw D
    Circulation; 2011 Mar; 123(10):1049-51. PubMed ID: 21357820
    [No Abstract]   [Full Text] [Related]  

  • 36. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New bioactive angiotensins formation pathways and functional involvements.
    Haulică I; Petrescu G; Slătineanu SM; Bild W; Mihaila CN; Ioniţă T
    Rom J Intern Med; 2004; 42(1):27-40. PubMed ID: 15529593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases.
    Huber G; Schuster F; Raasch W
    Pharmacol Res; 2017 Nov; 125(Pt A):72-90. PubMed ID: 28687340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.